Stockscreener 앱 받기
0.3176
5.19%
-0.0174
시간 외 거래:
.31
-0.0076
-2.39%
전일 마감가:
$0.335
열려 있는:
$0.3455
하루 거래량:
191.98K
Relative Volume:
0.48
시가총액:
$7.95M
수익:
$56.04M
순이익/손실:
$-20.39M
주가수익비율:
-0.1302
EPS:
-2.44
순현금흐름:
$-6.84M
1주 성능:
-7.13%
1개월 성능:
-34.65%
6개월 성능:
-57.20%
1년 성능:
-34.35%
1일 변동 폭
$0.2801
$0.3455
1주일 범위
$0.2801
$0.39
52주 변동 폭
$0.2801
$1.58
Cosmos Health Inc Stock (COSM) Company Profile
명칭
Cosmos Health Inc
전화
312-536-3102
주소
5 AGIOU GEORGIOU, PILEA, THESSALONIKI
COSM을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
COSM
Cosmos Health Inc
|
0.3176 | 7.95M | 56.04M | -20.39M | -6.84M | -2.44 |
|
MCK
Mckesson Corporation
|
682.49 | 85.53B | 344.58B | 2.83B | 1.63B | 21.84 |
|
COR
Cencora Inc
|
281.16 | 55.07B | 303.19B | 1.40B | -638.10M | 7.03 |
|
CAH
Cardinal Health Inc
|
131.17 | 32.56B | 222.16B | 1.31B | -486.00M | 5.36 |
|
HSIC
Henry Schein Inc
|
63.08 | 8.04B | 12.50B | 314.00M | 421.00M | 2.44 |
|
OMI
Owens Minor Inc
|
6.51 | 534.60M | 10.42B | -38.77M | 323.54M | -0.51 |
Cosmos Health Inc 주식(COSM)의 최신 뉴스
Cosmos Health Reports Full-Year 2024 Results: Revenue - GlobeNewswire
Cosmos Health Reports Full-Year 2024 Results: Revenue Increases 2% to $54.43 Million While Operating Expenses Decline 24.2% to $19.86 Million | COSM Stock News - GuruFocus
Cosmos Health Inc. Reports Year-End 2024 Financial Results Highlighting Revenue Growth and Strategic Developments - Nasdaq
Cosmos Health Inc. SEC 10-K Report - TradingView
Cosmos Health Further Expands Facility Upgrades Program at Cana - GuruFocus
Cosmos Health Receives Initial Orders Exceeding $500,000 for C-Scrub in the UK; Future Orders Booked at Accelerated Pace with Strong Profitability Anticipated Due to High Profit Margins - ACCESS Newswire
Cosmos Health secures deal for antiseptic drug production By Investing.com - Investing.com South Africa
Cosmos Health secures deal for antiseptic drug production - Investing.com
Cosmos Health Further Expands Facility Upgrades Program at Cana Laboratories and Signs 5-Year Contract Manufacturing Agreement with Pharmex for 1.5 Million Bottles of the Antiseptic Drug AMBITASOL 1L - GlobeNewswire
Cosmos Health Further Expands Facility Upgrades Program at Cana Laboratories and Signs 5-Year Contract… - Informazione.it
Massive Deal: Cosmos Health Secures 5-Year Contract for 1.5M Antiseptic Drug Units - Stock Titan
Cosmos Health Announces Launch Of Food Supplement Brand In Albania: Retail Sentiment Improves - MSN
Cosmos Health expands into Albania with new supplement brand - Investing.com
Cosmos Health expands into Albania with new supplement brand By Investing.com - Investing.com South Africa
Cosmos Health Launches Sky Premium Life in Albania through Partnership with Pharma Cell; Secures Initial $300,000 Order - The Manila Times
Cosmos Health Launches Sky Premium Life in Albania through - GlobeNewswire
Cosmos Health Lands Major $300K Deal in Strategic Albanian Market Entry - Stock Titan
Cosmos Holdings stock hits 52-week low at $0.34 amid market challenges - Investing.com India
Cosmos Health Enters into a Warrant Exchange Agreement, Replacing Structured Warrants with Plain-Vanilla Warrants - ACCESS Newswire
Cosmos Holdings stock hits 52-week low at $0.44 By Investing.com - Investing.com South Africa
Cosmos Holdings stock hits 52-week low at $0.44 - Investing.com India
Cosmos Health CEO acquires $44,999 in stock through debt exchange By Investing.com - Investing.com South Africa
Cosmos Health CEO acquires $44,999 in stock through debt exchange - Investing.com
Cosmos Holdings stock hits 52-week low at $0.46 - Investing.com India
Cosmos health CEO acquires shares worth $65,000 in debt exchange By Investing.com - Investing.com South Africa
Cosmos health CEO acquires shares worth $65,000 in debt exchange - Investing.com
Cosmos Health CEO Acquires Over 130K Shares Through Debt Exchange - TradingView
Cosmos Health Inc. (NASDAQ:COSM) Might Not Be As Mispriced As It Looks After Plunging 31% - simplywall.st
Cosmos Holdings stock hits 52-week low at $0.46 By Investing.com - Investing.com Canada
Cosmos Health Actively Exploring Spinoff of R&D Division into a Publicly Listed Standalone Biotech Company - ACCESS Newswire
Cosmos Health expands distribution of Avian Influenza kits - MSN
Cosmos Holdings Inc. Changes its Name to Cosmos Health Inc. and Announces a 1-For-25 Reverse Stock Split - ACCESS Newswire
Cosmos Health Expands Sky Premium Life Nutraceuticals Brand with 60 New SKUs as Global Growth Accelerates - ACCESS Newswire
Cosmos Health CEO Grigorios Siokas acquires $200,000 in stock By Investing.com - Investing.com Canada
Cosmos Health CEO Grigorios Siokas acquires $200,000 in stock - Investing.com India
Cosmos Health CEO Acquires Shares Through Debt Exchange Agreement - TradingView
Tuesday 2/25 Insider Buying Report: COSM, SEPN - Nasdaq
Bullish Cosmos Health Insiders Loaded Up On US$539.0k Of Stock - Yahoo Finance
Cosmos Health postpones securities offering By Investing.com - Investing.com South Africa
Cosmos Health postpones securities offering - Investing.com India
Cosmos Health Announces It will not Proceed with an Offering Under Its Form S-1 - ACCESS Newswire
Strategic Shift: Cosmos Health Postpones Capital Raise, Prioritizes Annual Report - StockTitan
Cosmos Health Inc. (NASDAQ:COSM) Short Interest Down 39.7% in January - Defense World
Cosmos Health Inc (COSM) 재무 분석
매출
순이익
현금흐름
주당 순 이익
7.63%
2.29%
자본화:
|
볼륨(24시간):